Here is one of the Street's prognostications, for Friday morning's coming New Merck earnings call:
. . . .Wall St. Earnings Expectations: The average estimate of analysts is for net income of 91 cents per share, an increase of 7.1% from the company’s actual earnings for the same quarter a year ago. . . . Analysts are projecting profit to increase by 9.1% versus last year to $3.73.
Analysts are projecting a revenuse increase of 4.4% from the year-earlier quarter to $11.61 billion. . . .
Will this be right? Too High? Too low? Do stay tuned, right here. Merck's NYSE-reported common stock price is off 3.7 percent, year to date, just FYI.
3 comments:
Don't know if you've been following Cafepharma-but a lot of people are getting axed in NJ.
Yes -- I've seen the threads on CafePharma. . .
I am waiting to get a reliable total -- as to the actual numbers -- then I'll post something. We ought to know that figure by Friday night.
THanks for the tip!
Quite helpful data, lots of thanks for your article.
youtube to mp3
Post a Comment